We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares

Delisted

AMYT was delisted on the 11th of April, 2023.

62 hedge funds and large institutions have $315M invested in Amryt Pharma plc American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

3% more capital invested

Capital invested by funds: $306M → $315M (+$9.61M)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

3% less funds holding

Funds holding: 6462 (-2)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $6K

Holders
62
Holders Change
-2
Holders Change %
-3.13%
% of All Funds
1.07%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
10
Increased
17
Reduced
7
Closed
10
Calls
Puts
$6K
Net Calls
-$6K
Net Calls Change
-$246K

AMYT Hedge Fund Activity: Q3 2022 in Review

62 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q3 2022, worth a combined $315M — up 3.1% from $306M a quarter earlier.

Fund positioning in AMYT was balanced in Q3 2022: 10 funds opened new positions, 10 closed out, 17 added to existing stakes and 7 trimmed.

The largest buyer was Man Group, opening a new position worth an estimated $9.77M. The largest seller was Nantahala Capital Management, cutting an estimated $933K.

  • 62 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q3 2022, down from 64 in Q2 2022.
  • Funds reported $315M of Amryt Pharma plc American Depositary Shares stock for Q3 2022, up 3.1% quarter-over-quarter.
  • 10 funds opened new Amryt Pharma plc American Depositary Shares positions in Q3 2022 and 10 closed out, a net change of 0 holders.
  • The largest Amryt Pharma plc American Depositary Shares buyer in Q3 2022 was Man Group, an estimated $9.77M added.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q3 2022 was Nantahala Capital Management, an estimated $933K sold.

Based on aggregated 13F filings for Q3 2022.